NextGen Day

Cebuano

English

Filipino

The bivalent coronavirus disease 2019 (Covid-19) vaccine, billed as an “updated” booster dose against the Omicron form, has received FDA approval for use.

On Tuesday, FDA Director General Samuel Zacate acknowledged that the organization has authorized the emergency use of bivalent shots made by Pfizer and Moderna.

Zacate, when questioned about the priority group and its suggested use, deferred to the Department of Health (DOH).

He stated in a text message that while the approval has been verified, “for the details, all Covid-related matters are being funneled to DOH Sec. (Ma. Rosario) Vergeire for proper and streamlined communication with (the) public.”

The DOH is acquiring the vaccines, according to Vergeire, in a briefing on Tuesday, “because publications and evidence have demonstrated” that they could better protect the public against Covid-19, particularly new versions.

To give the population broader protection, the reformulated shot contains elements from both the original SARS-COV-2 strain from 2019 and the Omicron variation.

By early 2023, the Philippines hopes to get the vaccine.

Cebuano

English

Filipino

Please follow and like us:

2

2k

20